Clinical Trial

JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)

Name: JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE) — clinical trial record (NCT06675422)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: JY231

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Early exploratory clinical study of the safety, tolerability and initial efficacy of JY231 injection in the treatment of active systemic lupus erythematosus (SLE)

Trial Details

NCT Number	NCT06675422
Lead Sponsor	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Conditions	Systemic Lupus Erythematosus (SLE)
Enrollment	20 participants
Start Date	2024-10-09
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-11-05